Connect with us

Health & Fitness

FDA Broadens Ticagrelor Indication to Stroke Prevention

In the THALES trial, ticagrelor plus aspirin led to a statistically significant reduction in stroke or death in with patients acute ischemic stroke or high-risk transient ischemic attack. FDA Approvals

Published

on

FDA Broadens Ticagrelor Indication to Stroke Prevention